" class="no-js "lang="en-US"> Nikki Kanani Archives - Medtech Alert
Tuesday, January 21, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days

More than one million booster jabs have been booked in the last three days as […]

NHS Offers Home Blood Pressure Checks to Save Thousands of Lives

Hundreds of thousands of people will be able to test their blood pressure at home, […]

Walk-in Sites Open Up For People To Get Covid-19 Booster Jab

Hundreds of walk-in sites across the country are now offering booster vaccines as the NHS […]

NHS Opens Online Covid-19 Vaccination Bookings For 12-15 Year Olds

Parents will be able to book covid-19 vaccinations online for their 12-15 year old children […]

NHS Delivers Over Three Million COVID Boosters in First Month

More than three million top up COVID-19 jabs have been delivered in just four weeks, […]

Over One Million Invited For Covid Booster Jabs This Week

Invitations to book a Covid booster jab will be sent to one and a half […]

NHS Begins Covid-19 Booster Vaccination Campaign

The NHS has started delivering Covid booster jabs to people in eligible groups from today, […]

NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England

NHS comment as the latest vaccine statistics published today show that 75% of people aged […]

Nightlife Industry Joins Covid-19 Vaccine Push for Young People

Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]

Theme Park Joins NHS Covid Vaccine Drive

Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more